As your immunity wanes from previous infection and vaccination, the best way to protect yourself against COVID-19 is to get the new COVID vaccine. There are three currently available — is one better ...
Novavax (NVX-CoV2373) is a vaccine used to reduce the risk of serious infection from the virus that causes COVID-19. Novavax can cause side effects that range from mild to serious. Examples include ...
Sept 21 (Reuters) - The European Medicines Agency (EMA) expects to decide on the use of Novavax's (NVAX.O), opens new tab updated COVID-19 vaccine in October, its director Emer Cooke said on Thursday.
GAITHERSBURG, Md., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will present at the Ladenburg Thalmann 2017 Healthcare Conference. Presentation details ...
Five years ago, Novavax (NASDAQ: NVAX) was a little-known clinical-stage biotech whose leading pipeline candidate was an influenza vaccine. Then came the pandemic. The company quickly grew in ...
GAITHERSBURG, Md., Nov. 12, 2024 /PRNewswire/ -- Novavax, Inc. (NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced its financial results and ...
GAITHERSBURG, Md., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will present at the Stifel 2017 Healthcare Conference ...
Vaccine appointments for kids remain limited, and Novavax shots are hard to come by. By Knvul Sheikh Knvul Sheikh has been writing about the development and distribution of coronavirus vaccines and ...
Good morning, and welcome to Novavax' Second Quarter 2024 Financial Results and Operational Highlights Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. Please ...
Novavax (NASDAQ: NVAX) shares soared more than 30% in one trading session this week. That's a huge gain for any stock. But it's particularly impressive for Novavax. The biotech stock has been in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results